Finance

Lists
NVCT:NASDAQ
Nuvectis Pharma Inc
US$21.00
-0.38%
(-0.080) 1D
US$21.00
0.00% (0.00)
After hours
Closed: ኖቬም 11, 4:00:00 ከሰዓት ጂ ኤም ቲ-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for NVCT...
Open
US$21.31
High
US$21.78
Low
US$20.60
Mkt. cap
722.17 ሚ
Avg. vol.
198.01 ሺ
Volume
0.00
52-wk high
US$29.28
52-wk low
US$5.77
EPS
-US$1.89
Beta
-0.21
Shares outstanding
34.39 ሚ
No. of employees
19
Open
US$21.31
High
US$21.78
Low
US$20.60
Mkt. cap
722.17 ሚ
Avg. vol.
198.01 ሺ
Volume
0.00
52-wk high
US$29.28
52-wk low
US$5.77
EPS
-US$1.89
Beta
-0.21
Shares outstanding
34.39 ሚ
No. of employees
19
News stories
From web sources and news partners
About Nuvectis Pharma Inc
CEO-
Employees19
Founded2020
HeadquartersFort Lee, ኒው ጄርዚ, ዩናይትድ ስቴትስ
SectorHealth Care
IndustryBiotechnology
Websitenuvectis.com
Analyst ratings
Based on 3 analysts giving stock ratings to NVCT in the past 3 months
Strong buy
Buy
3
Hold
0
Sell
0
12-month forecast
Based on 3 Wall Street analysts offering 12 month price targets for NVCT in the last 3 months.
Highest
Current US$21.00
US$39.00 (+85.71%)
Average
US$34.50 (+64.29%)
Lowest
US$30.00 (+42.86%)
Analyst
Recommendation
Action
Price target
Projected
Date
Naz Rahman
Maxim Group
Buy
Reiterated
US$30.00
+42.9%
11/04/2026
Joseph Pantginis
H.C. Wainwright
Buy
Reiterated
US$39.00
+85.7%
11/04/2026
Pete Stavropoulos
Cantor Fitzgerald
Buy
Initiated
-
-
08/24/2026
Christopher Liu
Lucid Capital
Buy
Maintained
US$34.00
+61.9%
08/05/2026
Jonathan Aschoff
Roth MKM
Buy
Reiterated
US$33.00
+57.1%
07/06/2026
Unknown Analyst
Roth MKM
Buy
Maintained
US$20.00
-4.8%
06/23/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
ዲሴም 2025
ማርች 2026
ጁን 2026
ሴፕቴ 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
5.09 ሚ
4.11 ሚ
4.68 ሚ
27.37 ሚ
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.53 ሚ
2.15 ሚ
2.51 ሚ
3.68 ሚ
Operating expense
7.62 ሚ
6.26 ሚ
7.20 ሚ
31.05 ሚ
Total operating expenses
7.62 ሚ
6.26 ሚ
7.20 ሚ
31.05 ሚ
Operating income
-7.62 ሚ
-6.26 ሚ
-7.20 ሚ
-31.05 ሚ
Other non operating income
-
-
-
-
EBT including unusual items
-7.31 ሚ
-6.05 ሚ
-7.02 ሚ
-30.07 ሚ
EBT excluding unusual items
-7.31 ሚ
-6.05 ሚ
-7.02 ሚ
-30.07 ሚ
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-7.31 ሚ
-6.05 ሚ
-7.02 ሚ
-30.07 ሚ
Net profit margin
-
-
-
-
Earnings per share
-
-
-
-
Interest and investment income
303.00 ሺ
210.00 ሺ
177.00 ሺ
979.00 ሺ
Interest expense
-
-
-
-
Net interest expenses
303.00 ሺ
210.00 ሺ
177.00 ሺ
979.00 ሺ
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-
-
-
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google መተግበሪያዎች